Ignite Creation Date:
2024-05-05 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00550771
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2007-10-29
Brief Title:
Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer Study P05048
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2010-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08-23
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-29
First Submit QC Date:
October 29 2007
Study First Post Date:
2007-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-10-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-15
Last Update Post Date:
2017-06-07
Last Update Post Date Type:
ACTUAL